Download PDF
Thromb Haemost 1997; 78(04): 1299-1300
DOI: 10.1055/s-0038-1657735
Letter to the Editor
Schattauer GmbH Stuttgart

Double Treatment of Severe Hepatic Veno-occlusive Disease after Allogeneic Peripheral Blood Progenitor Cell Transplantation with Recombinant Tissue Plasminogen Activator

Dietmar Söhngen
1   The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Ulli Bauser
1   The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Christiane Boogen
2   The Dept. of Clinical Chemistry, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Carlo Aul
1   The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Thomas Frieling
3   The Dept. of Gastroenterology and Hepatology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Ulrich Germing
1   The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Peter Schneider
1   The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Guido Kobbe
1   The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
,
Axel Heyll
1   The Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, 40225 Düsseldorf, Germany
› Author Affiliations
Further Information

Publication History

Received 26 1997

Accepted after resubmission 13 June 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dix SP, Wingard JR, Mullins RE, Jerkunica I, Davidson TG, Gilmore CE, York RC, Lin LS, Devine SM, Geller RB, Heffner LT, Hillyer CD, Holland HK, Winton EF, Saral R. Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplantation 1996; 17: 225-230
    PubMedGoogle Scholar
  • 2 McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116-122
    CrossrefPubMedGoogle Scholar
  • 3 Jones RJ, Lee KS, Beschomer WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbrenner LL, Santos GW, Saral R. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783
    CrossrefPubMedGoogle Scholar
  • 4 Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation: immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987; 127: 549-558
    PubMedGoogle Scholar
  • 5 Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H, Lehn P, Faure P, Drouet L. Use of prostaglandin El for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Brit J Haematol 1990; 74: 277-281
    CrossrefPubMedGoogle Scholar
  • 6 Baglin TP, Harper P, Marcus RE. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). Bone Marrow Transplantation 1990; 5: 439-441
    PubMedGoogle Scholar
  • 7 Laporte JP, Lesage S, Tilleui P, Najman A, Gorin NC. Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation. Lancet 1992; 339: 1057
    PubMedGoogle Scholar
  • 8 Goldberg SL, Shubert J, Rao AK, Redei I, Klumpp TR, Mangan KF. Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile. Bone Marrow Transplantation 1996; 18: 633-636
    PubMedGoogle Scholar
  • 9 Bearman SI, Lee JL, Baron AE, McDonald GB. Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 1997; 89: 1501-1506
    CrossrefPubMedGoogle Scholar